IP Library Granted Patent US 12,522,850
Granted Patent B2
US 12,522,850 · App. 17/787,568 · Granted Jan 13, 2026

Fluoroacetate dehalogenase mutant and application thereof

Inventors: Zhanbing Cheng (Shanghai, CN); Shaonan Ding (Shanghai, CN); Yanbing Xu (Shanghai, CN); Yao Huang (Shanghai, CN)
Assignee: ABIOCHEM BIOTECHNOLOGY (GROUP) CO., LTD.
C12P7/52C12N9/14C12N9/18C12P41/00C12Y301/01005C12Y308/01003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,522,850
App. No.
17/787,568
Granted
Jan 13, 2026
Kind
B2
Abstract

Disclosed in the present invention is a fluoroacetate dehalogenase mutant, a sequence of the fluoroacetate dehalogenase mutant comprising a mutated sequence having an amino acid residue H at position 155 and/or an amino acid residue W at position 156, as shown in SEQ ID NO: 1; the fluoroacetate dehalogenase mutant has activity catalyzing bromination of a substrate, particularly a 2-bromobutyric acid substrate. Also provided in the present invention is an application of said fluoroacetate dehalogenase mutant in the preparation of (R)-2-bromobutyric acid and/or (R)-2-hydroxybutyric acid. When using the fluoroacetate dehalogenase mutant of the present invention to prepare (R)-2-bromobutyric acid, production costs are low and stereoselectivity is high, facilitating industrialized production.

Claims (23)

1 . A fluoroacetate dehalogenase mutant, wherein the fluoroacetate dehalogenase mutant comprises the amino acid sequence of SEQ ID NO: 9, SEQ ID NO: 17, SEQ ID NO: 21, SEQ ID NO: 35, or SEQ ID NO: 51.

2 . A fluoroacetate dehalogenase mutant, wherein the fluoroacetate dehalogenase mutant is encoded by the nucleotide sequence of SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 18, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 36, or SEQ ID NO: 52.

3 . An isolated nucleic acid, wherein the nucleic acid encodes the fluoroacetate dehalogenase mutant of claim 1 .

4 . A recombinant expression vector comprising the nucleic acid of claim 3 .

5 . A transformant comprising the nucleic acid of claim 3 .

6 . A dehalogenase combination for catalyzing a halogenated substrate, wherein the dehalogenase combination comprises two or more of the fluoroacetate dehalogenase mutant of claim 1 .

7 . A catalyst combination, wherein the catalyst combination comprises (a) the fluoroacetate dehalogenase mutant of claim 1 , and (b) a lipase.

8 . A reaction system for a catalyst, wherein the reaction system comprises a substrate and a catalyst, wherein the substrate is 2-bromobutyric acid,

the catalyst comprises the fluoroacetate dehalogenase mutant of claim 1 .

9 . A method for preparing (R)-2-bromobutyric acid and/or (R)-2-hydroxybutyric acid by use of the fluoroacetate dehalogenase mutant of claim 1 .

10 . A preparation method of (R)-2-bromobutyric acid or (R)-2-hydroxybutyric acid, wherein the preparation method comprises following steps: a catalytic reaction is performed in the presence of the reaction system of claim 8 to obtain (R)-2-bromobutyric acid or (R)-2-hydroxybutyric acid, respectively; wherein the catalytic reaction has a reaction system with a temperature of 20-30; and/or, the catalytic reaction has a reaction time of 5-10 hours; wherein the catalytic reaction comprises a dehalogenation reaction, or a dehalogenation reaction and an ester hydrolysis reaction.

11 . A catalyst combination, wherein the catalyst combination comprises (a) the dehalogenase combination of claim 6 , and (b) a lipase.

12 . A reaction system for a catalyst, wherein the reaction system comprises a substrate and a catalyst, wherein the substrate is 2-bromobutyric acid,

the catalyst comprises the dehalogenase combination of claim 6 .

13 . A reaction system for a catalyst, wherein the reaction system comprises a substrate and a catalyst, wherein the substrate is methyl 2-bromobutyrate or ethyl 2-bromobutyrate, the catalyst comprises the catalyst combination of claim 7 .

14 . A reaction system for a catalyst, wherein the reaction system comprises a substrate and a catalyst, wherein the substrate is methyl 2-bromobutyrate or ethyl 2-bromobutyrate,

the catalyst comprises the catalyst combination of claim 11 .

15 . A preparation method of (R)-2-bromobutyric acid or (R)-2-hydroxybutyric acid, wherein the preparation method comprises following steps: a catalytic reaction is performed in the presence of the reaction system of claim 12 to obtain (R)-2-bromobutyric acid or (R)-2-hydroxybutyric acid, respectively; wherein the catalytic reaction has a reaction system with a temperature of 20-30° C.; and/or, the catalytic reaction has a reaction time of 5-10 hours; wherein the catalytic reaction comprises a dehalogenation reaction, or a dehalogenation reaction and an ester hydrolysis reaction.

16 . A preparation method of (R)-2-bromobutyric acid or (R)-2-hydroxybutyric acid, wherein the preparation method comprises following steps: a catalytic reaction is performed in the presence of the reaction system of claim 13 to obtain (R)-2-bromobutyric acid or (R)-2-hydroxybutyric acid, respectively; wherein the catalytic reaction has a reaction system with a temperature of 20-30° C.; and/or, the catalytic reaction has a reaction time of 5-10 hours; wherein the catalytic reaction comprises a dehalogenation reaction, or a dehalogenation reaction and an ester hydrolysis reaction.

17 . A preparation method of (R)-2-bromobutyric acid or (R)-2-hydroxybutyric acid, wherein the preparation method comprises following steps: a catalytic reaction is performed in the presence of the reaction system of claim 14 to obtain (R)-2-bromobutyric acid or (R)-2-hydroxybutyric acid, respectively; wherein the catalytic reaction has a reaction system with a temperature of 20-30° C.; and/or, the catalytic reaction has a reaction time of 5-10 hours; wherein the catalytic reaction comprises a dehalogenation reaction, or a dehalogenation reaction and an ester hydrolysis reaction.

18 . A fluoroacetate dehalogenase mutant, wherein the fluoroacetate dehalogenase mutant comprises the amino acid sequence of SEQ ID NO: 11 or SEQ ID NO: 23.

19 . The reaction system of claim 8 , wherein the 2-bromobutyric acid has a concentration of 0.02 g/ml-0.2 g/ml; and/or, the fluoroacetate dehalogenase mutant has a concentration of 2-20 U/ml.

20 . The reaction system of claim 13 , wherein the methyl 2-bromobutyrate or ethyl 2-bromobutyrate has concentration of 0.02 g/ml-0.2 g/ml; and/or, the fluoroacetate dehalogenase mutant has a concentration of 2-20 U/ml; and/or, the lipase has a concentration of 1-20 g/L.

Assignments (2)
CHANGE OF NAME Recorded Oct 29, 2024
From: ABIOCHEM BIOTECHNOLOGY CO, LTD
To: ABIOCHEM BIOTECHNOLOGY (GROUP) CO., LTD.
Reel/Frame 069269/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2022
From: CHENG, ZHANBING; DING, SHAONAN; XU, YANBING; HUANG, YAO
To: ABIOCHEM BIOTECHNOLOGY CO, LTD
Reel/Frame 061390/0921 →
Continuity (1)
Related Publication 20240182933A1 · Jun 6, 2024
References Cited (14)
US 20100286210A1 · Murata et al. · 2010 [cited by applicant]
CN 101048402A · 2007 [cited by applicant]
CN 109468347A · 2019 [cited by applicant]
EP 1806339A1 · 2007 [cited by applicant]
Chica et al. Curr Opin Biotechnol. Aug. 2005;16(4):378-84. (Year: 2005). [cited by examiner]
Singh et al. Curr Protein Pept Sci. 2017, 18, 1-11 (Year: 2017). [cited by examiner]
Bornscheuer et al. Curr Protoc Protein Sci. Nov. 2011;Chapter 26:Unit26.7. (Year: 2011). [cited by examiner]
International Search Report dated Sep. 14, 2020 issued in International Application No. PCT/CN2019/126785, with English translation, 7 pages. [cited by applicant]
Written Opinion of the International Searching Authority dated Sep. 14, 2020 issued in International Application No. PCT/CN2019/126785, with English translation, 7 pages. [cited by applicant]
Chan, Peter W.Y., et al., “Mapping the Reaction Coordinates of Enzymatic Defluorination,” Journal of the American Chemical Society, 2011, 133, pp. 7461-7468. [cited by applicant]
Levene, P.A., et al., “On Walden Inversion. X. On the Oxidation of 2-thiolcarboxylic Acids to the Corresponding Sulfonic Acids and on the Walden Inversion in the Series of 2-hydroxycarboxylic Acids,” Journal of Biologic… [cited by applicant]
Boschi, Francesca, et al.,“A synthesis of levetiracetam based on (S)-N-phenylpantolactam as a chiral auxiliary”, Tetrahedron: Asymmetry, 16(2005), pp. 3739-3745. [cited by applicant]
Wang, Jian-bo, et al.,“Investigating Substrate Scope and Enantioselectivity of a Defluorinase by a Stereochemical Probe,” J.Am.Chem.Soc., 2017, 139(32), 9 pages. [cited by applicant]
Yao, Peiyuan et al.,“Efficient Biosynthesis of (R)- or (S)-2-Hydroxybutyrate from L-Threonine through a Synthetic Biology Approach,” Advanced Synthesis and Catalysis, 2016, vol. 358(18), 7 pages. [cited by applicant]